Literature DB >> 22246977

Accidental intoxication with 60 mg intrathecal baclofen: survived.

Benjamin Berger1, Barbara Vienenkoetter, Mirjam Korporal, Andrea Rocco, Hans-Michael Meinck, Thorsten Steiner.   

Abstract

BACKGROUND: Intrathecal baclofen (ITB) is an effective and well-tolerated treatment for patients with severe spasticity. Intoxications are rare and usually iatrogenic, with reported intrathecal boluses varying between 0.050 and 30 mg.
METHODS: We here report the case of a 47-year-old woman with severe spastic paraplegia due to multiple sclerosis who, during a routine filling procedure, accidentally received a bolus of 60 mg ITB because of injection into the side-port instead of the reservoir of her ITB pump (Archimedes(®), Codman, Germany).
RESULTS: After a short period of dizziness, she lost consciousness and stopped breathing. She was immediately intubated, mechanically ventilated, and admitted to the intensive care unit. As specific treatment, she received cerebrospinal fluid drainage through a newly implanted lumbar catheter. A series of generalized and complex partial seizures were treated with levetiracetam and lacosamide. Acute autonomic dysfunction with episodic arterial hypo- and hypertensions was controlled by catecholamines and clonidine, respectively. Recurrent hyperthermia, however, responded neither to drugs nor to physical treatment. After 3 weeks, the patient was discharged without any relevant new neurologic signs or symptoms.
CONCLUSIONS: This case demonstrates that even excessive doses of ITB can let the patients survive without sequelae if treated promptly and offensively. A pertinent problem during detoxification is the question of when to restart ITB to avoid drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246977     DOI: 10.1007/s12028-011-9669-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  39 in total

1.  Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen.

Authors:  C Chabal; L Jacobson; G Terman
Journal:  Anesthesiology       Date:  1992-02       Impact factor: 7.892

2.  Baclofen withdrawal presenting as multiorgan system failure.

Authors:  P Sampathkumar; P D Scanlon; D J Plevak
Journal:  Anesth Analg       Date:  1998-09       Impact factor: 5.108

Review 3.  EEG changes in intrathecal baclofen overdose: a case report and review of the literature.

Authors:  T Fakhoury; B Abou-Khalil; B Blumenkopf
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1998-11

4.  Dantrolene treatment for abrupt intrathecal baclofen withdrawal.

Authors:  A Khorasani; W T Peruzzi
Journal:  Anesth Analg       Date:  1995-05       Impact factor: 5.108

5.  Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis.

Authors:  E Knutsson; U Lindblom; A Mårtensson
Journal:  J Neurol Sci       Date:  1974-11       Impact factor: 3.181

6.  Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features.

Authors:  Farzana P Darbari; Joseph J Melvin; Joseph H Piatt; Terry A Adirim; Sanjeev V Kothare
Journal:  Pediatr Neurol       Date:  2005-11       Impact factor: 3.372

7.  Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure.

Authors:  R K Reeves; K A Stolp-Smith; M W Christopherson
Journal:  Arch Phys Med Rehabil       Date:  1998-03       Impact factor: 3.966

8.  Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage.

Authors:  J Bardutzky; V Tronnier; S Schwab; H-M Meinck
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases.

Authors:  G Müller-Schwefe; R D Penn
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115

10.  Intrathecal baclofen for spasticity in cerebral palsy.

Authors:  A L Albright; A Cervi; J Singletary
Journal:  JAMA       Date:  1991-03-20       Impact factor: 56.272

View more
  4 in total

1.  Baclofen intoxication: a "fun drug" causing deep coma and nonconvulsive status epilepticus--a case report and review of the literature.

Authors:  Guido F Weißhaar; Marc Hoemberg; Katja Bender; Ursula Bangen; Peter Herkenrath; Frank Eifinger; Markus Rothschild; Bernhard Roth; André Oberthuer
Journal:  Eur J Pediatr       Date:  2012-06-23       Impact factor: 3.183

2.  Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.

Authors:  D Dressler; S Berweck; A Chatzikalfas; M Ebke; B Frank; S Hesse; M Huber; J K Krauss; K-H Mücke; A Nolte; H-D Oelmann; P W Schönle; M Schmutzler; H Pickenbrock; C Van der Ven; N Veelken; M Vogel; T Vogt; F Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2015-07-16       Impact factor: 3.575

3.  Application of high-resolution mass spectrometry to determination of baclofen in a case of fatal intoxication.

Authors:  Paweł Szpot; Agnieszka Chłopaś; Grzegorz Buszewicz; Grzegorz Teresiński
Journal:  Forensic Toxicol       Date:  2016-03-29       Impact factor: 4.096

Review 4.  Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis.

Authors:  Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.